Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies
Abstract Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory syndrome with characteristic clinical, radiological, and pathological features, and can be effectively treated with corticosteroid-based immunotherapies. The exact pathogenesis of CLIPPERS remains unclear, and specific diagnostic biomarkers are not available. According to the 2017 diagnostic criteria, probable CLIPPERS should be considered in middle-aged patients with subacute onset of pontocerebellar symptoms and typical punctuate and curvilinear gadolinium enhancement lesions (“salt-and-pepper” appearance) located in the hindbrain (especially pons) on magnetic resonance imaging. In addition, CLIPPERS-mimics, such as central nervous system (CNS) lymphoma, and several antibody-associated autoimmune CNS diseases (e.g., myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune glial fibrillary acidic protein astrocytopathy, and anti-N-methyl-d-aspartate receptor encephalitis), should be extensively excluded. The prerequisite for definite CLIPPERS is the perivascular T-cell-predominant inflammatory infiltration observed on pathological analysis. A biopsy is strongly suggested when clinical/radiological red flags are present. Most patients with CLIPPERS respond well to corticosteroids and have a good prognosis. Long-term low-dose corticosteroid maintenance therapy or corticosteroids coupled with immunosuppressants are recommended to prevent the recurrence of the syndrome. The potential progression of CLIPPERS to lymphoma has been suggested in some cases; therefore, at least 2-year clinical and radiological follow-up is essential. Here, we critically review the recent developments and provided an update on the clinical characteristics, diagnostic criteria, differential diagnoses, and therapeutic management of CLIPPERS. We also discuss the current controversies in this context that can be resolved in future research studies..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:271 |
|---|---|
| Enthalten in: |
Journal of neurology - 271(2024), 4 vom: 29. Jan., Seite 1747-1766 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Li, Er-Chuang [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Biopsy |
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s00415-024-12189-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055317189 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055317189 | ||
| 003 | DE-627 | ||
| 005 | 20240328072118.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240328s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00415-024-12189-4 |2 doi | |
| 035 | |a (DE-627)SPR055317189 | ||
| 035 | |a (SPR)s00415-024-12189-4-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.90 |2 bkl | ||
| 100 | 1 | |a Li, Er-Chuang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS): contemporary advances and current controversies |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Abstract Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is an inflammatory syndrome with characteristic clinical, radiological, and pathological features, and can be effectively treated with corticosteroid-based immunotherapies. The exact pathogenesis of CLIPPERS remains unclear, and specific diagnostic biomarkers are not available. According to the 2017 diagnostic criteria, probable CLIPPERS should be considered in middle-aged patients with subacute onset of pontocerebellar symptoms and typical punctuate and curvilinear gadolinium enhancement lesions (“salt-and-pepper” appearance) located in the hindbrain (especially pons) on magnetic resonance imaging. In addition, CLIPPERS-mimics, such as central nervous system (CNS) lymphoma, and several antibody-associated autoimmune CNS diseases (e.g., myelin oligodendrocyte glycoprotein antibody-associated disease, autoimmune glial fibrillary acidic protein astrocytopathy, and anti-N-methyl-d-aspartate receptor encephalitis), should be extensively excluded. The prerequisite for definite CLIPPERS is the perivascular T-cell-predominant inflammatory infiltration observed on pathological analysis. A biopsy is strongly suggested when clinical/radiological red flags are present. Most patients with CLIPPERS respond well to corticosteroids and have a good prognosis. Long-term low-dose corticosteroid maintenance therapy or corticosteroids coupled with immunosuppressants are recommended to prevent the recurrence of the syndrome. The potential progression of CLIPPERS to lymphoma has been suggested in some cases; therefore, at least 2-year clinical and radiological follow-up is essential. Here, we critically review the recent developments and provided an update on the clinical characteristics, diagnostic criteria, differential diagnoses, and therapeutic management of CLIPPERS. We also discuss the current controversies in this context that can be resolved in future research studies. | ||
| 650 | 4 | |a CLIPPERS |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Neuroinflammation |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pontocerebellar involvement |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Perivascular enhancement |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Corticosteroid |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Biopsy |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Lai, Qi-Lun |4 aut | |
| 700 | 1 | |a Cai, Meng-Ting |4 aut | |
| 700 | 1 | |a Fang, Gao-Li |4 aut | |
| 700 | 1 | |a Fang, Wei |4 aut | |
| 700 | 1 | |a Zheng, Yang |4 aut | |
| 700 | 1 | |a Du, Ye |4 aut | |
| 700 | 1 | |a Du, Bing-Qing |4 aut | |
| 700 | 1 | |a Shen, Chun-Hong |4 aut | |
| 700 | 1 | |a Qiao, Song |4 aut | |
| 700 | 1 | |a Ding, Mei-Ping |4 aut | |
| 700 | 1 | |a Zhang, Yin-Xi |0 (orcid)0000-0002-4462-171X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neurology |d Springer Berlin Heidelberg, 1891 |g 271(2024), 4 vom: 29. Jan., Seite 1747-1766 |w (DE-627)SPR005310695 |w (DE-600)1421299-7 |x 1432-1459 |7 nnns |
| 773 | 1 | 8 | |g volume:271 |g year:2024 |g number:4 |g day:29 |g month:01 |g pages:1747-1766 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00415-024-12189-4 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.90 |q VZ |
| 951 | |a AR | ||
| 952 | |d 271 |j 2024 |e 4 |b 29 |c 01 |h 1747-1766 | ||